Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

Fig. 1

a Locoregional recurrence-free survival in patients with recurrence score (RS) < 16 (n = 25) vs. RS ≥ 16 (n = 36) in the whole cohort (n = 61, p = 0.149). b Locoregional recurrence-free survival in patients with RS < 16 (n = 25) vs. RS ≥ 16 (n = 17) without adjuvant chemotherapy (n = 42) (p = 0.039)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us